-+ 0.00%
-+ 0.00%
-+ 0.00%
Genprex to Present TUSC2 Gene Therapy Research on Cellular Aging at GSA Meeting
Share
Listen to the news
Genprex to Present TUSC2 Gene Therapy Research on Cellular Aging at GSA Meeting
  • Genprex will present TUSC2 research Nov. 4, 2026, at the Gerontological Society of America’s annual scientific meeting.
  • Research with Meharry Medical College describes a cellular-resilience response to TUSC2 gene therapy in humans; TUSC2 is used in cancer candidate Reqorsa.
  • The findings could inform potential applications beyond oncology, but additional research is needed to determine whether they support therapeutic development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610280700PR_NEWS_USPR_____DA82880) on October 28, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending